JPMorgan Chase & Co. Acquires 20,310 Shares of Chemed Co. (NYSE:CHE)

JPMorgan Chase & Co. boosted its stake in Chemed Co. (NYSE:CHE - Free Report) by 8.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 266,786 shares of the company's stock after purchasing an additional 20,310 shares during the period. JPMorgan Chase & Co. owned about 1.77% of Chemed worth $141,343,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. UMB Bank n.a. grew its position in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after buying an additional 39 shares during the last quarter. Atala Financial Inc bought a new stake in Chemed in the fourth quarter valued at approximately $29,000. CBIZ Investment Advisory Services LLC increased its position in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the period. Trust Co. of Vermont bought a new position in Chemed during the 4th quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC lifted its position in shares of Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after purchasing an additional 34 shares during the period. 95.85% of the stock is owned by institutional investors.

Chemed Stock Performance

Shares of NYSE CHE traded down $21.05 during trading on Friday, hitting $598.17. 129,318 shares of the company traded hands, compared to its average volume of 95,734. The firm has a market capitalization of $8.76 billion, a price-to-earnings ratio of 30.23, a P/E/G ratio of 2.15 and a beta of 0.49. The business's fifty day moving average is $580.24 and its 200 day moving average is $567.98. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $632.22.

Remove Ads

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed's dividend payout ratio is 10.05%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CHE shares. Royal Bank of Canada lifted their price objective on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 3.32% of the stock is owned by insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.